| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-08-13 02:57:08 UTC |
|---|
| Update Date | 2023-02-21 17:16:47 UTC |
|---|
| HMDB ID | HMDB0003671 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 2-Heptanone |
|---|
| Description | 2-Heptanone, also known as butylacetone or heptan-2-one, belongs to the class of organic compounds known as ketones. These are organic compounds in which a carbonyl group is bonded to two carbon atoms R2C=O (neither R may be a hydrogen atom). Ketones that have one or more alpha-hydrogen atoms undergo keto-enol tautomerization, the tautomer being an enol. Thus, 2-heptanone is considered to be an oxygenated hydrocarbon lipid molecule. 2-Heptanone is a ketone with the molecular formula C7H14O. 2-Heptanone is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. 2-Heptanone exists in all living species, ranging from bacteria to humans. 2-Heptanone is a sweet, cinnamon, and coconut tasting compound. 2-Heptanone is found, on average, in the highest concentration within a few different foods, such as corns, cow milk, and peppermints. 2-Heptanone has also been detected, but not quantified in several different foods, such as tarragons, blackberries, tortilla chips, ceylon cinnamons, and evergreen blackberries. 2-Heptanone is one of the metabolites of n-heptane found in the urine of employees exposed to heptane in shoe and tire factories. 2-Heptanone, with regard to humans, has been found to be associated with several diseases such as ulcerative colitis, nonalcoholic fatty liver disease, crohn's disease, and hepatic encephalopathy; 2-heptanone has also been linked to the inborn metabolic disorder celiac disease. It is a colorless to white liquid with a banana-like, fruity odor. |
|---|
| Structure | InChI=1S/C7H14O/c1-3-4-5-6-7(2)8/h3-6H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Butylacetone | ChEBI | | Methyl N-amyl ketone | ChEBI | | Methyl pentyl ketone | ChEBI | | N-Amyl methyl ketone | ChEBI | | N-Pentyl methyl ketone | ChEBI | | Heptan-2-one | Kegg | | Methyl-N-amyl ketone | MeSH | | 1-Methylhexanal | HMDB | | 2-Oxoheptane | HMDB | | Amyl methyl ketone | HMDB | | Methyl amyl ketone | HMDB | | Methyl N-pentyl ketone | HMDB | | Pentyl methyl ketone | HMDB | | 2-Heptanone | ChEBI |
|
|---|
| Chemical Formula | C7H14O |
|---|
| Average Molecular Weight | 114.1855 |
|---|
| Monoisotopic Molecular Weight | 114.10446507 |
|---|
| IUPAC Name | heptan-2-one |
|---|
| Traditional Name | 2-heptanone |
|---|
| CAS Registry Number | 110-43-0 |
|---|
| SMILES | CCCCCC(C)=O |
|---|
| InChI Identifier | InChI=1S/C7H14O/c1-3-4-5-6-7(2)8/h3-6H2,1-2H3 |
|---|
| InChI Key | CATSNJVOTSVZJV-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ketones. These are organic compounds in which a carbonyl group is bonded to two carbon atoms R2C=O (neither R may be a hydrogen atom). Ketones that have one or more alpha-hydrogen atoms undergo keto-enol tautomerization, the tautomer being an enol. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbonyl compounds |
|---|
| Direct Parent | Ketones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ketone
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | -35 °C | Not Available | | Boiling Point | 149.00 to 150.00 °C. @ 760.00 mm Hg | The Good Scents Company Information System | | Water Solubility | 4.3 mg/mL at 25 °C | Not Available | | LogP | 1.98 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.81 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.0171 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.89 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 30.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1933.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 536.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 197.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 354.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 316.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 594.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 616.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 122.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1277.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 405.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1276.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 419.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 389.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 506.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 495.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 26.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2-Heptanone,1TMS,isomer #1 | CCCCC=C(C)O[Si](C)(C)C | 1091.2 | Semi standard non polar | 33892256 | | 2-Heptanone,1TMS,isomer #1 | CCCCC=C(C)O[Si](C)(C)C | 1053.7 | Standard non polar | 33892256 | | 2-Heptanone,1TMS,isomer #1 | CCCCC=C(C)O[Si](C)(C)C | 1102.1 | Standard polar | 33892256 | | 2-Heptanone,1TMS,isomer #2 | C=C(CCCCC)O[Si](C)(C)C | 1049.5 | Semi standard non polar | 33892256 | | 2-Heptanone,1TMS,isomer #2 | C=C(CCCCC)O[Si](C)(C)C | 1050.7 | Standard non polar | 33892256 | | 2-Heptanone,1TMS,isomer #2 | C=C(CCCCC)O[Si](C)(C)C | 1111.6 | Standard polar | 33892256 | | 2-Heptanone,1TBDMS,isomer #1 | CCCCC=C(C)O[Si](C)(C)C(C)(C)C | 1305.6 | Semi standard non polar | 33892256 | | 2-Heptanone,1TBDMS,isomer #1 | CCCCC=C(C)O[Si](C)(C)C(C)(C)C | 1254.4 | Standard non polar | 33892256 | | 2-Heptanone,1TBDMS,isomer #1 | CCCCC=C(C)O[Si](C)(C)C(C)(C)C | 1296.3 | Standard polar | 33892256 | | 2-Heptanone,1TBDMS,isomer #2 | C=C(CCCCC)O[Si](C)(C)C(C)(C)C | 1260.0 | Semi standard non polar | 33892256 | | 2-Heptanone,1TBDMS,isomer #2 | C=C(CCCCC)O[Si](C)(C)C(C)(C)C | 1244.6 | Standard non polar | 33892256 | | 2-Heptanone,1TBDMS,isomer #2 | C=C(CCCCC)O[Si](C)(C)C(C)(C)C | 1310.7 | Standard polar | 33892256 |
|
|---|
| Disease References | | Hepatic encephalopathy |
|---|
- Goldberg EM, Blendis LM, Sandler S: A gas chromatographic--mass spectrometric study of profiles of volatile metabolites in hepatic encephalopathy. J Chromatogr. 1981 Dec 11;226(2):291-9. [PubMed:7320160 ]
| | Ulcerative colitis |
|---|
- Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21. [PubMed:17314143 ]
- Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25. [PubMed:26806034 ]
| | Nonalcoholic fatty liver disease |
|---|
- Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27. [PubMed:23454028 ]
| | Celiac disease |
|---|
- Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, Gagliardi F, Laghi L, Crecchio C, Guerzoni ME, Gobbetti M, Francavilla R: Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011 Oct 4;11:219. doi: 10.1186/1471-2180-11-219. [PubMed:21970810 ]
| | Crohn's disease |
|---|
- Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25. [PubMed:26806034 ]
| | Perillyl alcohol administration for cancer treatment |
|---|
- Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec 22. [PubMed:22284503 ]
|
|
|---|